Sign in

CIK 0001672619

  • Non-accelerated filer

Enliven Therapeutics, Inc.

Sign in to watch
Ticker
ELVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811523849
Phone
+1 650-547-5814
Business address
205 PARK ROAD, BURLINGAME, CA, 94010
Former names
IMARA Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,819,567
in 6 filings, $1.2M under 10b5-1 plans

Net −$1,819,567. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-17 Collins Helen Louise CHIEF MEDICAL OFFICER Exercise or conversion 10b5-1 +5,000 $2.48 $12K 30,000
2026-11-17 Collins Helen Louise CHIEF MEDICAL OFFICER Sale 10b5-1 −4,939 $46.83 $231K 25,061
2026-11-17 Collins Helen Louise CHIEF MEDICAL OFFICER Sale 10b5-1 −61 $47.60 $3K 25,000
2026-11-17 Collins Helen Louise CHIEF MEDICAL OFFICER Exercise or conversion · Stock Option (right to buy) 10b5-1 −5,000 96,268
2026-10-30 Kunkel Lori Anne Director Exercise or conversion +3,741 $1.12 $4K 45,625
2026-10-30 Kunkel Lori Anne Director Exercise or conversion +7,300 $18.30 $134K 52,925
2026-10-30 Kunkel Lori Anne Director Exercise or conversion · Stock Option (right to buy) −3,741 0
2026-10-30 Kunkel Lori Anne Director Exercise or conversion · Stock Option (right to buy) −7,300 30,582
2026-10-19 Hohl Benjamin CHIEF FINANCIAL OFFICER Exercise or conversion 10b5-1 +6,018 $14.85 $89K 44,018
2026-10-19 Hohl Benjamin CHIEF FINANCIAL OFFICER Sale 10b5-1 −6,018 $38.48 $232K 38,000
2026-10-19 Hohl Benjamin CHIEF FINANCIAL OFFICER Exercise or conversion · Stock Option (right to buy) 10b5-1 −6,018 175,000
2026-10-19 Collins Helen Louise CHIEF MEDICAL OFFICER Exercise or conversion 10b5-1 +5,000 $2.48 $12K 30,000
2026-10-19 Collins Helen Louise CHIEF MEDICAL OFFICER Sale 10b5-1 −5,000 $38.47 $192K 25,000
2026-10-19 Collins Helen Louise CHIEF MEDICAL OFFICER Exercise or conversion · Stock Option (right to buy) 10b5-1 −5,000 101,268
2026-10-14 BALL KRISTINE M Director Grant or award · Stock Option (right to buy) +23,394 23,394
2026-10-01 Garland J. Scott Director Exercise or conversion +13,000 $15.47 $201K 13,000
2026-10-01 Garland J. Scott Director Sale −13,000 $46.67 $607K 0
2026-10-01 Garland J. Scott Director Exercise or conversion · Stock Option (right to buy) −13,000 46,372
2026-09-17 Hohl Benjamin CHIEF FINANCIAL OFFICER Exercise or conversion 10b5-1 +3,982 $14.85 $59K 44,018
2026-09-17 Hohl Benjamin CHIEF FINANCIAL OFFICER Sale 10b5-1 −3,535 $50.03 $177K 40,483

Page 1 of 42 · 829 trades